Secreted indicators of androgen receptor activity in breast cancer pre-clinical models

PURPOSE: Accumulating evidence has attracted attention to the androgen receptor (AR) as a biomarker and therapeutic target in breast cancer. We hypothesized that AR activity within the tumor has clinical implications and investigated whether androgen responsive serum factors might serve as a minimal...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanamura, Toru, Christenson, Jessica L., O’Neill, Kathleen I., Rosas, Emmanuel, Spoelstra, Nicole S., Williams, Michelle M., Richer, Jennifer K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567567/
https://www.ncbi.nlm.nih.gov/pubmed/34736512
http://dx.doi.org/10.1186/s13058-021-01478-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567567/
https://www.ncbi.nlm.nih.gov/pubmed/34736512
http://dx.doi.org/10.1186/s13058-021-01478-9

Ejemplares similares